Primary management of early stage cervical cancer (IA1-IB) and appropriate selection of adjuvant therapy.

Cervical cancer is the third most common gynecologic malignancy in the United States but the leading gynecologic cancer worldwide. Most patients will present with clinical early-stage disease (International Federation of Gynecology and Obstetrics [FIGO] stage IA1-IB). These patients are a clinically heterogeneous group, and primary treatment can be either surgery or radiotherapy. Standard surgery is either radical hysterectomy with lymphadenectomy (stage IA2-IB2) or simple hysterectomy for microinvasive disease (stage IA1). Interest has been increasing in using conservative fertility-sparing surgery through radical trachelectomy as an option for select patients with early-stage disease who want future fertility. Primary radiotherapy is delivered as a combination of external-beam teletherapy and brachytherapy. It is given with concurrent cisplatin-based chemotherapy, based on 5 large randomized controlled trials that showed significant improvement in overall survival with the addition of chemotherapy. Using either radical surgery or radiation therapy in stage IB disease yields 5-year survival rates of 87% to 92%. The addition of postoperative adjuvant radiation with concurrent chemotherapy is recommended in patients with high- or intermediate-risk disease after radical hysterectomy to reduce risk for recurrence and improve progression-free survival. In select patients with stage IB2 disease with bulky tumors undergoing primary chemoradiation, adjuvant hysterectomy may provide benefit after treatment.

[1]  D. Bodurka,et al.  Quality of life and sexual functioning in cervical cancer survivors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  P. Maisonneuve,et al.  Carcinoma of the cervix uteri. , 2001, Journal of epidemiology and biostatistics.

[3]  D. Levine,et al.  Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: technique and review of the literature. , 2006 .

[4]  F. Landoni,et al.  Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer , 1997, The Lancet.

[5]  A. Covens,et al.  Surgery Insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer , 2007, Nature Clinical Practice Oncology.

[6]  E. Wertheim The extended abdominal operation for carcinoma uteri : based on 500 operated cases (Gradd H transl.) , 1912 .

[7]  B N Bundy,et al.  Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  P. Mathevet,et al.  Laparoscopic vaginal radical trachelectomy , 2000, Cancer.

[9]  D. Kumar,et al.  Clinical Implications of Tumor Volume Measurement in Stage I Adenocarcinoma of the Cervix , 1993, Obstetrics and gynecology.

[10]  P J Eifel,et al.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. , 1999, The New England journal of medicine.

[11]  A. Gadducci,et al.  The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a Cooperation Task Force (CTF) study. , 2003, European journal of gynaecological oncology.

[12]  B. Monk A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: Follow-up of a Gynecologic Oncology Group study , 2007 .

[13]  V. Dandolu,et al.  Ovarian conservation at the time of hysterectomy for benign disease. , 2005, Obstetrics and gynecology.

[14]  W. Koh,et al.  Adjuvant therapy for high-risk, early stage cervical cancer. , 2000, Seminars in radiation oncology.

[15]  B N Bundy,et al.  A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. , 1999, Gynecologic oncology.

[16]  S Nag,et al.  The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States. , 1999, Gynecologic oncology.

[17]  B. Erickson,et al.  The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. , 2000, International journal of radiation oncology, biology, physics.

[18]  B. Rosen,et al.  A comparison of laparascopic-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer. , 2004, Gynecologic oncology.

[19]  R. Kurman,et al.  Microinvasive Carcinoma of the Cervix , 1976, Obstetrics and gynecology.

[20]  J. L. Benedet,et al.  STAGE IA CARCINOMA OF THE CERVIX REVISITED , 1996, Obstetrics and gynecology.

[21]  P. Grigsby,et al.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  P. Shaw,et al.  Prognostic factors for relapse and pelvic lymph node metastases in early stage I adenocarcinoma of the cervix. , 1999, Gynecologic oncology.

[23]  B. Goff,et al.  The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma. , 2000, Gynecologic oncology.

[24]  B. Sevin,et al.  Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. , 1990, Gynecologic oncology.

[25]  B N Bundy,et al.  Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. , 1999, The New England journal of medicine.

[26]  B N Bundy,et al.  Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. , 1999, The New England journal of medicine.

[27]  M. Rotman,et al.  Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. , 2003, Gynecologic oncology.

[28]  G. Thomas,et al.  Pretreatment surgical staging of patients with cervical carcinoma , 1999 .

[29]  T. Colgan,et al.  Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years. , 2001, Gynecologic oncology.